| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | -3.36 M USD | -747576 USD | -872132 USD | -675361 USD | 3.12 M USD |
| Depreciation & Amortization | 294611 USD | 10567 USD | 8393 USD | 2212 USD | — |
| Stock-Based Compensation | 58602 USD | — | — | — | — |
| Capital Expenditures | — | 55367 USD | 45500 USD | 8698 USD | — |
| Cash Flow from Investing | -3.58 M USD | -3.13 M USD | -45500 USD | -8698 USD | — |
| Cash Flow from Financing | 8.90 M USD | 9.32 M USD | 1.80 M USD | 933219 USD | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — |
| Free Cash Flow | — | -802943 USD | -917632 USD | -684059 USD | 2.65 M USD |
Haoxi Health Technology Ltd. is a holding company that provides digital marketing solutions in China, with a client base concentrated in the healthcare and medical aesthetics industries. The company focuses on online short video and social-media-based advertising, offering integrated services that span campaign planning, creative content production, media placement, and ongoing data-driven optimization. Haoxi Health Technology distributes advertisements through major Chinese platforms such as Douyin, Toutiao, WeChat, and Sina Weibo via media partners, aiming to help advertisers acquire, convert, and retain consumers across these channels. Its role in the market is centered on connecting healthcare-related advertisers with targeted digital audiences, leveraging performance-oriented marketing techniques and closed-loop campaign management. Founded in 2018 and headquartered in Beijing, China, Haoxi Health Technology operates within the communication services sector, specifically the advertising and online marketing segment, serving as a specialized intermediary between healthcare brands and the country’s large and highly engaged mobile internet user base.